Spun out of GlaxoSmithKline Pharmaceuticals (GSK) in 2010, Transpharmation was created to be a CRO with a difference; cross therapeutic area expertise in translational pharmacology from bench to bedside.
A CRO should offer technologies you do not have in your own company. Investment in technology, bringing capabilities together, underpins our desire to innovate & produce multiple endpoints to a single study.
We are constantly looking for novel preclinical/clinical assays, technologies and endpoints that increase your success. Wherever possible we strive to publish our research in peer reviewed journals.
In order to offer a complete best in class service, it is sometimes necessary to use like minded partners. Follow the link below to some partners we believe can enhance your screening options.